Consequently, we challenged the IL-23R (wild-type) and IL-23R-Y416FΔICD signaling deficient mice in open-chest ischemia/reperfusion experiments with 50 min of ischemia and 4 weeks of reperfusion (Fig. 5A). The gene discussed is IL23R; the disease is ischemia.